Request to exercise option - nimh toxicological evaluation of novel ligands contract (HHSN271201400006I), for the period of september 1, 2018 august 31, 2019. SRI international:1110101 [18-005935]
Ended Awarded Last action
- Contract number
- 75N95018F00011
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $38,614
Award facts
- Contract value 100% obligated
- $38,613.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$3,368 | |
| Original award | $41,982 |
Quick answers
Who was awarded contract 75N95018F00011?
75N95018F00011 was awarded to Sri International by National Institute on Drug Abuse (National Institutes of Health) on August 7, 2018.
How much is contract 75N95018F00011 worth?
The government has obligated $38,614 on 75N95018F00011.
Is contract 75N95018F00011 an order under another contract?
Yes. 75N95018F00011 is a delivery order under HHSN271201400006I, an indefinite delivery contract.
Was contract 75N95018F00011 competed?
The extent of competition for 75N95018F00011 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award